An early-stage biotech company developing drugs to reduce multi-morbidity and earn an indication for aging.
We are an early-stage biotech company developing drugs to reduce multi-morbidity and earn an indication for aging. This role involves creating a brand-new regulatory path and collaborating with global health authorities to prove that keeping people healthy longer can be recognized as an official indication.
An early-stage biotech company developing drugs to reduce multi-morbidity and earn an indication for aging.